Autosomal dominantSMA

Diseases that are recessive require two gene flaws — usually one from each parent, but occasionally one from one parent and one that occurs as a fetus is being formed. People who have only one gene flaw for a recessive disease are said to be carriers and usually show no symptoms. Often, a family has no idea that some members are carriers until a child is born with a recessive disorder.

Genetic testing for chromosome 5-related SMA is available for those suspected of having the disease, including unborn babies, and for carriers of the disease. Genetic testing is expanding and changing rapidly, but its implications can be complex. It’s best to talk with a genetic counselor before embarking on testing. (A genetic counseling referral can be obtained through your MDA Care Center or your primary care physician).

Experience Generative AI by Getty Images: a solution that pairs Getty Images' vast content and data with the latest AI technology.

Discover the latest in high-quality user-generated content, including exclusive images and videos you can only find here.

Flaws in the cytoplasmic dynein 1 heavy chain 1 (DYNC1H1) gene on chromosome 14 have been found to lead to another rare form of SMA called SMA-LED.

Additionally, SMA can be caused by mutations in the DYNC1H1 gene on chromosome 14. This form is dominantly inherited, meaning that only one DYNC1H1 gene mutation, inherited from one parent, is sufficient to cause the disease.

Normally, SMN1 genes produce full-length and fully functional SMN protein. But when the SMN1 gene has mutations, as in the chromosome 5-related form of SMA, insufficient levels of SMN protein are produced.

Tap into Getty Images' global scale, data-driven insights, and network of more than 340,000 creators to create content exclusively for your brand.

Explore collections of diverse images and videos, crafted through strategic brand partnerships and customer needs that ensure genuine visual storytelling for every project.

sma-led prognosis

Include MDA in your will to advance research and support those with neuromuscular diseases. Contact Kathleen Riordan for more information.

SMALED1

Explore millions of royalty‑free vectors in a variety of formats and styles, including exclusives you can only find on Getty Images.

SMA is characterized by the loss of motor neurons, nerve cells in the spinal cord. It is classified as a motor neuron disease.

It is imperative to diagnose SMA as early as possible, ideally before symptom onset, because delay in treatment can worsen the course of the disease and create permanent damage to motor neurons. The best way to identify SMA before symptoms appear is to screen all newborns for the SMN1 exon 7 deletion. Since Spinraza (nusinersen), a disease-modifying therapy, was approved in 2016 by the US Food and Drug Administration (FDA) and early treatment showed positive outcomes, the secretary of the US Department of Health approved the addition of SMA to newborn screening panels.1 For more information, visit SMA Added to National List of Disorders to Screen for at Birth.

People can have multiple copies of the SMN2 gene. Normally, the number varies between zero and eight copies. In the chromosome 5-related form of SMA, the more SMN2 gene copies a person has, the more functional SMN protein is available. As a result, the milder the disease course is likely to be. Having three or more copies of the SMN2 gene is associated with a less severe disease manifestation.

Explore the latest in news, sports, and entertainment coverage, featuring exclusive images that can’t be found anywhere else.

Discover millions of royalty‑free, exclusive illustrations in a variety of styles, from conceptual to contemporary, and more.

A mutation in the SMN1 gene leads to a deficiency of a motor neuron protein called SMN, which stands for “survival of motor neuron.” As its name implies, this protein is responsible for gene expression necessary for normal motor neuron function.

Genetic testing can tell how many SMN2 genes a person has and roughly predict the course of SMA that is likely to result.

Check out the latest in entertainment, from the red carpet to center stage, featuring celebrity coverage you can only get from us.

SMA-LED DYNC1H1

Genetic information moves from its storage form as DNA to a set of instructions known as RNA, from which protein molecules are made. Most of the RNA instructions from the SMN1 gene tell the cell to make full-length SMN protein. Most of the instructions from the SMN2 gene tell the cell to make short SMN protein.

More rarely, a mutation in an X-chromosome gene called UBE1 causes X-linked SMA. The UBE1 gene carries instructions for ubiquitin-activating enzyme 1, which normally helps attach a molecular tag to proteins to mark them for destruction.

The most common form of SMA (types 1-4) is caused by a defect (mutation) in the SMN1 gene on chromosome 5. (People have two SMN1 genes — one on each chromosome 5). In 94% of all SMA cases, this mutation involves a deletion in a segment known as exon 7. This area is located in the long arm of the chromosome 5, in the 5q13.2 region (chromosomes have two “arms”: a short one, identified by the letter “p,” and a long one, identified by the letter “q”).

Browse millions of royalty-free images and photos, available in a variety of formats and styles, including exclusive visuals you won't find anywhere else.

SMALED2

Non 5qSMA

Chromosome 5-related SMA (types 1 through 4) follows an inheritance pattern known as autosomal recessive. (The autosomes are the numbered chromosomes — that is, all the chromosomes except the X and the Y, which determine gender.)

Search the latest news photos & coverage of world events with high-quality images and video content, available in 4K & HD formats.

Access the best of Getty Images with our simple subscription plan. Millions of high-quality images, video, and music options are waiting for you.

If both parents are carriers of the chromosome 5 gene flaw, the risk of each pregnancy producing a child with the disease is 25%. This risk doesn’t change no matter how many children a couple has.

SMA severity also may depend on disease modifiers, which don't cause disease but can affect (modify) onset and severity by influencing various biological pathways. Levels of both plastin 3 protein and ZPR1 protein have been identified as modifiers of SMN-related SMA and could become therapeutic targets. In addition, testing for these protein levels could help predict disease severity, and insight into the activities of these proteins could shed new light on disease processes.

Streamline your workflow with our best-in-class digital asset management system. Organize, control, distribute and measure all of your digital content.

Explore the latest in news, sports, and entertainment coverage, featuring exclusive videos that can’t be found anywhere else.

Check out millions of royalty‑free videos, clips, and footage available in 4K and HD, including exclusive visual content you won't find anywhere else.

From the sidelines to the pitch, check out the latest and greatest images and videos from must-see, global sports events.

Explore Getty Images Music, powered by Triple Scoop Music’s library of original audio content, which includes music, sound effects, and royalty-free tracks.

X-linked SMA is inherited via the X chromosome. Females have two X chromosomes, and those with a gene flaw on one X chromosome are usually considered carriers of an X-linked disease. Males, however, have no second X to protect them from the full effects of a gene flaw on the X chromosome and show the full effects of such a flaw.

A neighboring gene on chromosome 5, called SMN2, also produces SMN protein. Most of the protein made from instructions carried by SMN2 genes is not functional, but a small percentage, around 10 to 15% is functional.